US Material Events SEC 8-K Filings — April 01, 2026

01-04-2026

Community West Bancshares (CWBC) completed its merger with United Security Bancshares (UBFO) on April 1, 2026, in an all-stock transaction where UBFO shareholders received 0.4520 CWBC shares per UBFO share, valued at approximately $185.5 million based on CWBC's $23.30 closing price on March 31, 2026. The combined company has approximately $5 billion in total assets, retains banking offices across 13 counties and 31 communities in Central California, and features a 14-member board with 12 directors from CWBC and 2 from UBFO. Leadership transitions include James J. Kim as CEO and President, Daniel J. Doyle as Chairman, new Vice Chairman Jagroop “Jay” Gill, and Dennis R. Woods as Chairman Emeritus, alongside retirements of Suzanne M. Chadwick, Tom L. Dobyns, William S. Smittcamp, and upcoming Daniel C. Cunningham.

• ·Shareholder approvals at special meetings on March 30, 2026.
• ·Planned systems conversion in summer 2026.
• ·Exchange ratio: 0.4520 shares of CWBC common stock per share of UBFO common stock.
• ·This is the seventh acquisition for the company, following Community West Bancshares (2024), Folsom Lake Bank (2017), Sierra Vista Bank (2016), Visalia Community Bank (2013), Service 1st Bank (2008), and Bank of Madera County (2005).

01-04-2026

Piedmont Natural Gas Company, Inc. (PNG), a subsidiary of Duke Energy CORP, completed the sale of its Piedmont Tennessee business (PNG TN) to Spire, Inc. on March 31, 2026, for expected proceeds of $2.48 billion. Pro forma results for the year ended December 31, 2025, show net income increasing to $887 million from historical $440 million, driven by a $693 million gain on sale; however, operating revenues declined to $1,911 million from $2,237 million and core operating income (excluding gain) fell to approximately $560 million from $696 million due to divestiture of the segment, which contributed $149 million to historical operating income. The pro forma balance sheet as of December 31, 2025, reflects higher cash of $1,334 million but lower total assets of $11,830 million versus historical $12,470 million.

• ·Purchase agreement entered July 27, 2025.
• ·Proceeds subject to closing adjustments; $800M used for debt repayment, reducing notes payable and interest expense by $22M.
• ·Estimated tax impact: $347M offset to cash from deferred/current taxes at 24% statutory rate.
• ·Transaction does not qualify as discontinued operation.

01-04-2026

Suncrete, Inc. executed a Securities Exchange Agreement dated March 26, 2026, with holders of all 26,000,000 Senior Preferred Units of Concrete Partners Holding, LLC (CPH), exchanging them for 26,000 shares of Series A Convertible Perpetual Preferred Stock at a ratio of 1,000 units per share. The exchange closes immediately prior to the Acquisition Merger under the October 9, 2025 Business Combination Agreement involving Haymaker Acquisition Corp. 4 (SPAC), with accrued dividends paid in cash beforehand and tax-deferred treatment intended under Section 351. No financial impacts or declines are disclosed, positioning this as a preparatory restructuring for the SPAC merger.

• ·Exchange ratio: 1,000 Senior Preferred Units per share of Series A Preferred Stock
• ·Filing of Series A Certificate of Designation with Delaware Secretary of State prior to closing
• ·Permitted under Credit Agreement dated July 29, 2024 (as amended October 17, 2025 and later)

01-04-2026

Brag House Holdings, Inc. entered into Amendment No. 3 to its Merger Agreement with Brag House Merger Sub, Inc. and House of Doge Inc., dated March 26, 2026, adding new Section 3.5(i) that imposes modified lock-up restrictions on shares of Purchaser Common Stock received by Company Group A Stockholders (e.g., 80% at Effective Time, reducing to 0% after 270 days), Company Group B Stockholders (80% at Effective Time, to 0% after 270 days), and RSU holders (90-day full lock-up plus 5% daily volume limit thereafter). The amendment also extends the outside date for termination under Section 9.2(a) from April 30, 2026, to May 29, 2026, and requires Purchaser to implement stop transfer orders and legends. No financial terms were altered.

• ·Original Merger Agreement dated October 12, 2025; prior amendments on November 26, 2025 (No. 1) and February 2, 2026 (No. 2).
• ·Lock-up exceptions for domestic relations order, divorce settlement, will, laws of descent and distribution, or applicable law.
• ·Purchaser to instruct Exchange Agent for stop transfer orders and restrictive legends on shares for 90, 180, and 270 days post Effective Time.

01-04-2026

Consensus Cloud Solutions, Inc. promoted and appointed Adam Varon (61) as Chief Financial Officer and Karel Krulich (50) as Chief Accounting Officer, effective April 1, 2026. Varon's compensation includes an annual base salary of $345,000, eligibility for up to $150,000 annual bonus in 2026, a February 2026 equity grant valued at approximately $400,000 (8,818 performance-based RSUs and 8,818 time-based RSUs), and an additional equity grant of approximately $300,000 (12,637 time-based RSUs). Krulich's package comprises a $327,000 base salary, up to $100,000 bonus, a February 2026 equity grant worth approximately $375,000 (8,267 performance-based RSUs and 8,267 time-based RSUs), and an additional grant of approximately $275,000 (11,584 time-based RSUs).

• ·Equity grants vest over 3 years: 50% of performance-based RSUs based on 2026 financial metrics, remaining 50% based on stock price targets; time-based RSUs in 5 tranches.
• ·Appointments previously announced.
• ·Event and filing date: April 1, 2026.

01-04-2026

McCormick & Co Inc (MKC-V) filed an 8-K on April 01, 2026, reporting entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements/exhibits under Item 9.01. The filing attaches Exhibit 99.1, a press release dated March 31, 2026. No specific financial metrics, agreements details, or performance data were disclosed in the provided content.

• ·Filing Type: 8-K
• ·Items Reported: 1.01 (Material Definitive Agreement), 7.01 (Regulation FD Disclosure), 9.01 (Financial Statements and Exhibits)
• ·Subcategory: Material Agreement Entry
• ·Exhibit 99.1: Press Release dated March 31, 2026

01-04-2026

On March 30, 2026, Nuveen Churchill Private Capital Income Fund entered into an Incentive Fee Waiver Agreement with Churchill PCIF Advisor LLC, waiving 50% of the incentive fee based on income for February 2026, while declaring gross regular distributions of $0.170 per share payable April 28, 2026. As of February 28, 2026, the Fund's aggregate NAV was $1.5 billion, investment portfolio fair value $2.4 billion with a weighted average yield of 8.70%, and it received $120.0 million in Q1 2026 gross subscriptions; however, short-term returns remained modest with Class I shares at 0.21% for 1-month, 1.15% for 3-months, and 0.74% YTD, alongside 3.2% of outstanding shares tendered in the March repurchase offer.

• ·As of February 28, 2026, NAV per share: Class I $24.16, Class S $24.09, Class D $24.16.
• ·Portfolio composition at fair value: 93.08% first-lien debt, 2.75% second-lien debt, 2.02% mezzanine/structured debt, 2.15% equity; 96% floating rate debt.
• ·Average position size 0.30%; top 10 holdings each ~1% of fair value.
• ·Gross regular distributions: Class I $0.170 (net $0.170), Class S $0.170 gross/$0.153 net, Class D $0.170 gross/$0.165 net.

01-04-2026

Zymeworks Inc. (Nasdaq: ZYME) announced the appointment of Kristin Stafford as Chief Financial Officer, effective April 1, 2026, to support strategic planning, capital allocation, and value creation. Stafford brings extensive experience from Royalty Pharma plc, BioPharma Credit plc, Ernst & Young LLP, and Deloitte. No financial metrics or performance changes were disclosed in the announcement.

• ·Stafford served as Senior Vice President, Chief Accounting Officer at Royalty Pharma since December 2018; previously Vice President, Finance at Royalty Pharma and CFO of BioPharma Credit plc (2016-2018).
• ·Stafford is a CPA, holds B.Sc. in business administration from Sonoma State University, and is currently a Board Member at Novocure.
• ·Filing includes standard forward-looking statement risks, such as clinical trial failures, regulatory delays, and partnership challenges.

01-04-2026

SharonAI Holdings Inc. (NASDAQ:SHAZ) announced a significant 5-year US$1.25BN Total Contract Value (TCV) AI Cloud infrastructure agreement with ESDS Software Solutions Ltd., including an option to extend for an additional 2 years. The deal involves deploying an 8K B300 cluster in an existing Australian data center, with revenue expected to commence in Q3 2026. CEO James Manning emphasized robust demand across enterprise, hyperscale, research, government, and AI native sectors.

• ·Filing Date: April 01, 2026
• ·Agreement deployment within one of the company’s existing data center providers in Australia
• ·Investor Relations disclosures via https://sharonai.com/investors/, X account (sharon__ai), and LinkedIn (sharon-AI)

01-04-2026

Cal-Maine Foods, Inc. (NASDAQ: CALM) announced the appointment of Dudley D. Wooley to its Board of Directors effective April 1, 2026, succeeding Jim Poole who recently passed away. Wooley, CEO of Ross & Yerger Insurance, Inc., brings over three decades of experience in risk management, business strategy, governance, and capital allocation, aligning with the company's long-term growth strategy toward diversified earnings. Board Chair Dolph Baker highlighted Wooley's value in navigating market dynamics and enhancing earnings visibility.

• ·Wooley holds MBA from Millsaps College, BS in Mathematics from Vanderbilt University, and certifications: CPCU, CRM, CIC, AAI.
• ·Serves as Trustee of Jones Family Trusts overseeing assets for ~170 beneficiaries.
• ·Recent risks noted: HPAI outbreak impacting flocks in March 2026; Echo Lake Foods acquisition completed June 2, 2025; ceased 'controlled company' status April 14, 2025.

01-04-2026

Keurig Dr Pepper Inc. (KDP) has acquired 96.22% of the shares of JDE Peet’s N.V., combining it with KDP’s Keurig coffee business to form a global coffee powerhouse as part of its strategic transformation. KDP plans to separate into two independent U.S.-listed companies—Beverage Co. and Global Coffee Co.—targeting operational readiness by year-end 2026, with Rafael Oliveira appointed as CEO of the future Global Coffee Co. KDP has annual revenue of more than $16 billion and 30,000 employees, while JDE Peet’s generated EUR 9.9 billion in 2025 sales with more than 21,000 employees.

• ·Post-Closing Acceptance Period for JDE Peet’s shares: March 30, 2026, to April 13, 2026
• ·Last day of trading JDE Peet’s shares on Euronext Amsterdam: April 29, 2026
• ·Delisting of JDE Peet’s shares from Euronext Amsterdam: April 30, 2026
• ·Offer Memorandum dated January 15, 2026

01-04-2026

RYTHM, Inc. announced amendments to its existing trademark and recipe license agreements with an indirect wholly-owned subsidiary of Green Thumb Industries Inc., effective April 1, 2026. Green Thumb will pay RYTHM an aggregate fixed annual cash fee of $70 million, subject to annual increases equal to two times a Consumer Price Index-based escalator. This framework strengthens the long-term licensing arrangement, providing predictable revenue and supporting RYTHM’s Nasdaq listing.

• ·Agreements cover brand intellectual property including RYTHM, incredibles, Beboe, Dogwalkers, Doctor Solomon’s, &Shine, and Good Green

01-04-2026

Green Thumb Industries Inc. amended its Trademark and Recipe License Agreements with RYTHM, Inc. subsidiaries effective April 1, 2026, transitioning licensing fees from revenue-based to fixed annual cash payments of $70 million collectively for brands including RYTHM Premium Cannabis, incredibles, Beboe, Dogwalkers, Doctor Solomon's, &Shine, and Good Green. Fees are payable monthly and subject to annual increases based on two times a CPI escalator, with no other terms changed. As a significant shareholder in RYTHM, Green Thumb is positioned to benefit from its growth.

01-04-2026

Bruker Corporation (Nasdaq: BRKR) announced the appointment of Thierry L. Bernard to its Board of Directors, effective April 1, 2026. Mr. Bernard, current CEO of QIAGEN N.V., brings decades of experience in life-science tools, diagnostics, and prior roles at bioMérieux SA. Chairman Frank H. Laukien highlighted Bernard's strategic track record to support Bruker's growth in post-genomic life sciences and diagnostics.

• ·Mr. Bernard joined QIAGEN in 2015 to lead molecular diagnostics and was named CEO in 2019; he plans to step down upon successor appointment.
• ·15 years at bioMérieux SA in roles including Corporate Vice President for Global Commercial Operations, Investor Relations, and Greater China Region.
• ·Named Chair of AdvaMedDx board in 2023 and joined Neogen Corporation board in 2024.
• ·Education: Sciences Po Paris, London School of Economics, College of Europe, Harvard Business School, Centro de Comercio Exterior de Barcelona.

01-04-2026

Cadrenal Therapeutics, Inc. entered into a Warrant Inducement Agreement on March 31, 2026, under which a holder will exercise existing warrants for 571,430 shares of common stock at a reduced price of $4.50 per share (from $16.50), providing approximately $2.5 million in gross proceeds for working capital. In exchange, the company issued new Series B-1 and Series B-2 warrants to purchase 571,430 shares each at $4.50 per share, representing significant potential dilution, along with placement agent warrants for 37,143 shares to H.C. Wainwright & Co., LLC and a 7.0% cash fee. A 15-day lock-up on new share issuances follows closing, expected April 1, 2026.

• ·New Warrants exercisable for 5 years (Series B-1) and 18 months (Series B-2) from Resale Registration Statement effectiveness.
• ·Company to file Resale Registration Statement within 30 days of March 31, 2026, and use reasonable efforts for effectiveness within 60 days (or 90 days if SEC review).
• ·Beneficial ownership limit of 4.99% or 9.99% for New Warrant holders.
• ·15-day lock-up on new Common Stock or equivalents post-closing.

01-04-2026

Elauwit Connection, Inc. (Nasdaq: ELWT) announced the appointment of James Di Bartolo as Chief Financial Officer effective April 2, 2026, replacing departing CFO Sean Arnette, who helped prepare the company for its IPO and initial public quarters. Executive Chairman Dan McDonough expressed excitement about Di Bartolo's financial acumen, capital markets experience from Goldman Sachs, Barclays, and others, to support growth in multifamily housing. No financial metrics or performance changes were disclosed.

• ·James Di Bartolo's prior roles: VP Structured Investing at Goldman Sachs (Oct 2024-Mar 2026), VP Strategic Transactions at Barclays (Jun 2021-Oct 2024)
• ·Company's 10-K for year ended Dec 31, 2025 filed Mar 31, 2026

01-04-2026

Toyota Motor Credit Corporation entered into a Revolving Credit Agreement with Toyota Motor Sales, U.S.A., Inc., dated April 1, 2026, establishing a $5 billion revolving line of credit. The facility allows for loans during the Commitment Period ending March 31, 2027, with repayment and reborrowing permitted until the Commitment Termination Date. Interest accrues at agreed Applicable Rates based on federal rates, with no performance metrics or changes reported.

• ·Commitment Termination Date: March 31, 2027
• ·Irrevocable Loan Notices required 15 days prior to Borrowing Date
• ·Interest Periods in one-month increments, no shorter than one month

01-04-2026

Primo Brands Corporation, along with Triton Water Holdings, Inc. and Primo Water Holdings Inc., entered into the Fifth Amendment to its First Lien Credit Agreement dated March 31, 2026, to refinance $3,090,000,000 of existing 2025 Refinancing Term Loans with new 2026 Refinancing Term Loans of the same aggregate principal amount. The proceeds will repay the existing loans and cover related fees and expenses, with no Event of Default existing before or after the transaction. All representations and warranties remain true and correct, and solvency is confirmed post-transaction.

• ·Amendment effective upon satisfaction of conditions including receipt of legal opinions, solvency certificate, and no Event of Default.
• ·Arrangers for the 2026 Refinancing Term Loans: Morgan Stanley Bank, N.A., BofA Securities, Inc., and others.
• ·2026 Refinancing Term Loans may be Term SOFR Rate Loans or Base Rate Loans.

01-04-2026

Ondas Inc. (ONDS) completed its acquisition of World View Enterprises, Inc., integrating World View's Stratollite® stratospheric ISR platform with Ondas' autonomous systems to create a multi-domain, AI-enabled intelligence platform spanning stratosphere, air, and ground. The deal expands Ondas' addressable market in defense and security, supported by a partnership with Palantir Technologies for AI-driven data fusion. In connection, Ondas granted inducement RSUs for 2,309,934 shares and stock options for 1,745,000 shares at $9.02 exercise price to 26 new employees.

• ·RSUs: 1,329,934 shares vest one-third on closing (April 1, 2026), one-third on October 1, 2026, one-third on April 1, 2027; 980,000 shares vest one-third on April 1, 2027 then one-twelfth quarterly for eight quarters starting July 1, 2027.
• ·Stock options for 1,745,000 shares vest one-third on April 1, 2027 then one-twelfth quarterly for eight quarters starting July 1, 2027, subject to continued employment.

01-04-2026

Great Lakes Dredge & Dock Corporation filed its Third Amended and Restated Certificate of Incorporation as Exhibit 3.1 to an 8-K, significantly reducing authorized capital stock to 1,000 shares of Common Stock with a par value of $0.0001 per share. The document outlines standard Delaware corporate provisions, including limitations on director and officer liability for breaches of fiduciary duty, comprehensive indemnification rights, and advancement of expenses for directors and officers. This update accompanies 8-K items indicating completion of an acquisition or disposition, changes in control, board departures and elections, and potential delisting or suspension notices.

• ·Registered office: 251 Little Falls Drive, Wilmington, County of New Castle, Delaware 19808
• ·Registered agent: Corporation Service Company
• ·Board has power to amend bylaws

01-04-2026

Comenity Bank and Comenity Servicing LLC executed the Sixth Addendum to the Sixth Amended and Restated Service Agreement, effective April 1, 2026, amending Services in Appendix A (including Digital Engineering for Omnichannel Platform, Mobile App, Loyalty and Rewards; Servicing and Core Processing Engineering for VCARS, IVR, Jack Henry, Fiserv platforms, Servicing AI Assistant) and Performance Standards in Appendix B. Amendments reorganize standards such as adding and deleting 99.9% availability targets for PLP Services Rewards Website Fulfillment on a monthly basis. The Agreement, originally dated January 1, 2025, continues in full force and effect except as modified.

• ·Original Sixth Amended and Restated Service Agreement dated January 1, 2025
• ·Amendments detailed in Exhibit A (Services) and Exhibit B (Performance Standards)

01-04-2026

Star Holdings deconsolidated a Venture developing a multifamily project in Asbury Park, NJ, after full repayment of its $10.6 million mezzanine loan on March 27, 2026, release of an $80.0 million guaranty, and resignation as manager. Pro forma balance sheet as of December 31, 2025 shows total assets declining $78.6 million to $491.6 million, with real estate net down $78.4 million but cash rising $14.0 million to $64.1 million; pro forma 2025 operations reflect revenues up $10.8 million to $120.9 million and net loss narrowing to $64.4 million from $70.8 million, though allocable to common shareholders slightly worsens to $(4.91) per share.

• ·Mezzanine loan originally scheduled to mature in June 2033.
• ·Pro forma adjustments include $1.5M gain on sale of land and development asset to Venture, partially offset by $0.2M loss on deconsolidation.
• ·Deferred expenses and other assets, net includes transfer of $2.1M restricted cash to cash equivalents.
• ·Land and development, net includes transfer of $0.8M in tax increment financing bonds.

01-04-2026

Whirlpool Corporation reported the termination of James Peters' employment on March 30, 2026, after he stepped down from his roles as Executive Vice President, Chief Financial and Administrative Officer, and President, Whirlpool Asia, effective January 1, 2026, as part of ongoing talent planning. Under the Waiver and Release Agreement, Peters will receive $3,046,500 in severance payments in two installments, eligibility for a prorated 2026 annual incentive award, and vesting of 20,000 restricted stock units contingent on compliance with waivers, restrictive covenants, and cooperation obligations.

• ·First severance installment payable within 30 days of March 30, 2026; second in March 2027.
• ·Prorated annual incentive under 2026 Executive Performance Excellence Plan determined in February 2027 based on target percentage and company performance.
• ·Restrictive covenants in effect for two years post-termination; ongoing cooperation covenant.

01-04-2026

On March 31, 2026, Greg Campbell resigned from the Board of Directors of Newton Golf Company, Inc. (NWTG), effective immediately, with no disagreement on the company's operations, policies, or practices. The filing was signed by Akinobu Yorihiro, Interim Chief Executive Officer and Chief Technology Officer. No other changes or compensatory arrangements were disclosed.

• ·Company is an emerging growth company.
• ·Common stock trades as NWTG on Nasdaq Stock Market LLC, par value $0.01 per share.
• ·Principal executive offices: 551 Calle San Pablo, Camarillo, CA 93012.

01-04-2026

On March 26, 2026, Bunge Global SA's Board of Directors approved the Executive Integration Incentive Program, a one-time performance-based restricted stock unit (PBRSU) plan for senior officers including the CEO, tied to cumulative run-rate cost synergy targets from the Viterra Limited acquisition integration over the 2026-2028 performance period. Key grants include 63,281 PBRSUs to CEO Gregory Heckman, 19,501 to COO Julio Garros, 12,099 to CFO John Neppl, 7,959 to EVP Christos Dimopoulos, and 3,900 to Chief Legal Officer Joseph Podwika. PBRSUs vest upon performance certification and continued employment through settlement.

• ·Performance period: January 1, 2026 to December 31, 2028, based on cumulative run-rate cost synergy targets.
• ·Vesting subject to Compensation Committee certification, continued employment, and for CEO/CFO, compliance with shareholder-approved Executive Management Team compensation cap.

01-04-2026

On March 31, 2026, Design Therapeutics, Inc. appointed David Shapiro, M.D. as a Class III director, effective immediately, with a term ending at the 2027 annual meeting of stockholders. Dr. Shapiro was also appointed to the Nominating and Corporate Governance Committee. Compensation includes annual cash retainers of $40,000 for Board service and $5,000 for Committee service, plus an initial option grant for 60,000 shares vesting over three years and a prorated grant for 7,500 shares vesting over one year.

• ·Initial option grant vests monthly over a three-year period.
• ·Prorated annual option grant vests monthly over a one-year period.
• ·Company entered into standard indemnification agreement with Dr. Shapiro.

01-04-2026

EPAM Systems, Inc.'s Board of Directors approved a grant of restricted stock units (RSUs) valued at $3,000,000 to Viktar Dvorkin, Senior Vice President and Global Head of Advanced Engineering, Cloud & Enterprise Platforms, effective March 31, 2026, under the 2025 Long Term Incentive Plan to provide retention incentives. The RSUs vest in equal one-third portions on the first, second, and third anniversaries of the grant date, subject to continuous employment, with acceleration provisions for death, disability, qualified retirement, or certain terminations.

• ·RSUs subject to forfeiture if employment terminates without qualifying events (death, disability, qualified retirement, or qualifying termination under Executive Severance Plan).
• ·RSU Agreement filed as Exhibit 10.1.

01-04-2026

ARMOUR Residential REIT, Inc. confirmed the April 2026 cash dividend for its Common Stock at $0.24 per share (record date April 15, 2026; payment date April 29, 2026), consistent with guidance released on March 25, 2026. The Company also confirmed Q2 2026 monthly cash dividends for Series C Preferred Stock at $0.14583 per share for April (payment April 27), May (payment May 27), and June (payment June 29). Dividends are determined at the Board's discretion considering results of operations, cash flows, financial condition, and market conditions.

• ·ARMOUR has elected to be taxed as a REIT and must distribute substantially all ordinary REIT taxable income to maintain status.
• ·Dividends in excess of current tax earnings and profits are generally not taxable to common stockholders.
• ·Investor contact: Gordon M. Harper at (772) 617-4340; Company address: 3001 Ocean Drive, Suite 201, Vero Beach, Florida 32963.

01-04-2026

American Assets Trust, Inc. (NYSE: AAT) amended and restated its credit agreement, increasing the revolving line of credit from $400 million to $500 million and extending its maturity to April 1, 2030 (with two six-month extension options). The $100 million term loan's maturity was also extended to April 1, 2030 (with one twelve-month extension option). This enhances the company's borrowing capacity and financial flexibility.

• ·Company headquartered in San Diego, California, with properties in Southern California, Northern California, Washington, Oregon, Texas, and Hawaii.
• ·Formed in 2011 to succeed American Assets, Inc., founded in 1967.

01-04-2026

Commercial Vehicle Group (CVGI) announced that Chief Financial Officer Andy Cheung will resign effective April 15, 2026, to become CFO of a mid-cap publicly traded company. Angie O’Leary, current Corporate Controller and Chief Accounting Officer, has been promoted to Interim CFO while retaining her existing roles. The company reaffirmed its full-year 2026 outlook from its Q4 2025 earnings release on March 10, 2026, and stated it does not intend to initiate a search for a permanent CFO replacement at this time.

• ·Angie O’Leary joined CVG as Senior Vice President, Corporate Controller and Chief Accounting Officer in December 2020; previously held roles at Vertiv Holdings Co. from May 2017 to December 2020, including Interim Corporate Controller, and at Deloitte & Touche LLP from January 2004 to May 2017, culminating as Senior Manager – Audit.
• ·Angie O’Leary holds a Bachelor of Science in Business Administration and Master of Accounting from The Ohio State University (2003) and is a Certified Public Accountant since 2005.
• ·Investor contacts: Michelle.Hards@cvgrp.com; Ross Collins or Nathan Skown at Alpha IR Group (15004906036.2).

01-04-2026

Natera, Inc.'s Board of Directors increased from ten to eleven members and appointed Eric Rubin as a Class I director effective March 26, 2026, based on the recommendation of the Nominating, Corporate Governance and Compliance Committee. Dr. Rubin was determined to be independent under Nasdaq standards, appointed to the same committee, and will receive cash and equity compensation consistent with other non-employee directors, with no family relationships or material interests disclosed.

• ·Dr. Rubin’s initial term as Class I director expires at the 2028 annual meeting of stockholders.
• ·Initial equity award to Dr. Rubin vests as to one-third on each of March 26, 2027, 2028, and 2029.
• ·Company entered into an Indemnification Agreement with Dr. Rubin.

01-04-2026

ON24, Inc. filed an 8-K with Exhibit 3.1, the Fourteenth Amended and Restated Certificate of Incorporation, reducing authorized common stock to 1,000 shares with $0.001 par value, likely in connection with a merger or acquisition completion (Item 2.01), change in control (Item 5.01), delisting (Item 3.01), and security holder rights modification (Item 3.03). The document includes standard governance provisions such as director liability limitations, corporate opportunity waivers (excluding executive officers), opt-out from DGCL Section 203, and exclusive Delaware Chancery Court forum selection. No financial performance metrics are reported.

• ·Registered office: 251 Little Falls Drive, County of New Castle, Wilmington, Delaware 19808
• ·Board authorized to amend bylaws by majority vote
• ·Directors indemnified to fullest extent under Delaware law

01-04-2026

Nexscient, Inc. (NXNT) completed the acquisition of Flipside AI for $6.20 million, consisting of $600,000 cash, $450,000 convertible note, and 6,846,000 shares of restricted common stock, enhancing its Physical AI data engineering capabilities. Anthony S. De Luna, Flipside AI's founder and CEO, was appointed as Nexscient's Chief Technology Officer and Board Director. The deal positions Nexscient to capitalize on the AI robotics market projected to grow from $16.1 billion in 2024 to $124.8 billion by 2030.

• ·Acquisition includes satisfaction of all customary closing conditions, multi-step reorganization, regulatory filings, and government clearances.
• ·Flipside AI founded in 2010, pivoted to AI data engineering in 2018; serves automotive OEMs, Tier-1 suppliers, autonomous vehicle programs, robotics developers, and satellite intelligence platforms.
• ·Anthony S. De Luna has over three decades of experience, including XML at Innodata Inc. (1990s), EPUB at Barnes & Noble (2000s), and Physical AI from 2018.

01-04-2026

ServiceNow, Inc. entered into a Credit Agreement dated April 1, 2026, acting as Borrower, with JPMorgan Chase Bank, N.A. as Administrative Agent and various lenders party thereto. The agreement establishes facilities for revolving borrowings, swingline loans, and letters of credit, governed by standard terms including representations, covenants, and events of default. No specific commitment amounts or financial metrics are detailed in the provided content.

• ·Filing Type: 8-K, Items: 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), 9.01 (Financial Statements and Exhibits)
• ·Filing Date: April 01, 2026
• ·Subcategory: Material Agreement Entry
• ·Schedules include Commitments (2.01), Swingline Commitments (2.04), Existing Letters of Credit (2.05A), LC Commitments (2.05B), Existing Liens (6.01), Existing Subsidiary Debt (6.03)

01-04-2026

Cyclerion Therapeutics (CYCN) and Korsana Biosciences announced a definitive all-stock merger agreement, with the combined company operating as Korsana Biosciences (ticker: KRSA) and backed by approximately $380 million in private financing to fund operations into 2029, including KRSA-028 clinical milestones in 2027. However, pre-merger Cyclerion shareholders will own only about 1.5% of the combined entity, representing significant dilution. The transaction is expected to close in Q3 2026, subject to approvals.

• ·Merger closing expected in Q3 2026, subject to stockholder approvals, SEC registration effectiveness, HSR waiting period, and customary conditions
• ·KRSA-028 Phase 1 healthy volunteer data expected mid-2027; interim proof-of-concept data on amyloid plaque clearance in Alzheimer's patients by end-2027
• ·Conference call on April 1, 2026, at 8:00 am ET
• ·Combined company leadership: Jonathan Violin as CEO; Korsana's board to lead, chaired by Tomas Kiselak

01-04-2026

On March 31, 2026, the Board of Directors of Alkami Technology, Inc. approved the appointment of Jeffrey Fox and Judson Linville as new directors, effective immediately following the 2026 Annual Meeting of Stockholders. The Board size will increase from 9 to 11 directors, with Class I and Class III each expanding from 3 to 4 members. Both new directors bring extensive experience in financial services and technology, with no reportable related-party transactions.

• ·Mr. Linville's term as Class III director expires at 2027 annual meeting.
• ·Mr. Fox's term as Class I director expires at 2028 annual meeting.
• ·New directors will receive compensation per the Company's non-employee director program described in the March 31, 2025 proxy statement.
• ·No transactions or relationships reportable under Item 404(a) of Regulation S-K.
• ·Board to determine committee assignments post-appointment.

01-04-2026

Booking Holdings Inc. (BKNG) appointed Kurt Sievers, retired CEO of NXP Semiconductors, to its Board of Directors effective April 1, 2026, bringing experience in technology, mobility, and global markets from roles including leading NXP's acquisition of Marvell’s Wi-Fi Connectivity Business Unit and the 2015 merger with Freescale Semiconductor. Concurrently, Director Lynn Radakovich announced her retirement from the Board effective at the company's Annual Meeting in June 2026 after a decade of service providing leadership in global business, technology, sales, and marketing.

• ·Kurt Sievers served as President and CEO of NXP Semiconductors from 2020 until retirement in 2025; previously President from 2018 and joined Executive Management Team in 2009.
• ·Kurt Sievers currently serves on boards of Capgemini SE (Strategy & CSR and Compensation Committees) and supervisory board of Daimler Truck Holding AG.
• ·Filing date: April 01, 2026; Items 5.02, 7.01, 9.01.

01-04-2026

NovaBay Pharmaceuticals, Inc. amended its Second Amended and Restated Certificate of Incorporation to change its name to Stablecoin Development Corporation, effective at 4:15 p.m. Eastern Time on April 2, 2026. The Board of Directors adopted the amendment via resolutions under Sections 141 and 242 of the Delaware General Corporation Law, without a stockholder vote. The certificate was signed by CEO Michael Kazley on March 31, 2026.

• ·Corporation originally incorporated on April 19, 2010.
• ·Amendment amends Article I of the Second Amended and Restated Certificate of Incorporation.

01-04-2026

Comstock Inc. entered into a Second Note Amendment Agreement with Georges Trust on March 30, 2026, extending the maturity of a promissory note with $4,290,000 remaining principal from April 15, 2026, to July 15, 2026. This follows a prior amendment in August 2025 where the company issued 1,500,000 shares of common stock, now valued above the principal amount, with net proceeds from their sale intended to satisfy the note. While the extension provides breathing room, the debt obligation persists without full repayment.

• ·First Note Amendment Agreement dated August 8, 2025, disclosed in 8-K filed August 12, 2025.
• ·Form S-3 registration statement for resale of 1,500,000 shares filed November 21, 2025, declared effective December 10, 2025.
• ·Net proceeds from Noteholder's sale of shares to be applied to note; excess shares/cash returned to Company.

01-04-2026

Enova International, Inc. entered into amendments to four credit facilities on March 30-31, 2026, increasing commitments across its subsidiaries' RAOD Facility (Class A to $300,000,000 from $200,000,000; Class B to $55,263,157.89 from $36,842,105.26), NCR 2022 Facility to $275,000,000 from $200,000,000, NC LOC 2024 Facility to $200,000,000 from $150,000,000, and Headway Facility (Class A to $465,000,000 from $365,000,000; Class B to $156,183,000 from $122,595,000). These changes expand the company's revolving loan and note issuance capacities. No declines or flat commitments were reported.

• ·Amendments to be filed as exhibits in Q1 2026 10-Q.
• ·RAOD Facility originally dated December 17, 2018; NCR 2022 dated October 21, 2022; NC LOC 2024 dated February 21, 2024; Headway dated May 25, 2023.

01-04-2026

Medalist Diversified REIT, Inc. completed dispositions of five properties in late 2025 and early 2026, including Greenbrier Property for $11,000,000, Parkway Property for $7,825,000, and Franklin Square Property for $24,100,000, using proceeds to repay approximately $24 million in mortgages and boosting cash to $19,483,519 on the pro forma balance sheet as of December 31, 2025. Total assets decreased to $65,467,891 with investment properties net at $25,723,677 and mortgages payable reduced to $19,709,183, improving shareholders' equity to $15,890,259. However, the pro forma statement of operations for the year ended December 31, 2025 shows total revenue declining 55% to $4,724,834 and net loss attributable to common shareholders widening to $(3,396,461) or $(2.70) per share from historical $(1.90).

• ·Salisbury Property disposed October 23, 2025; Buffalo Wild Wings and United Rentals Properties disposed December 30, 2025; Greenbrier February 13, 2026; Parkway February 27, 2026; Franklin Square March 30, 2026.
• ·Pro forma loss per share $(2.70) basic and diluted; historical $(1.90).
• ·Pro forma accumulated deficit $(32,300,582) improved from historical $(38,761,731).

01-04-2026

Gray Media, Inc. entered into the Sixth Amendment to its Fifth Amended and Restated Credit Agreement, dated as of March 31, 2026, with Wells Fargo Bank, National Association as Administrative Agent and the Required Revolving Credit Lenders, restating the Credit Agreement, its Schedules and Exhibits in their entirety, and amending the Guaranty Agreement and Security Agreement. The amendment becomes effective upon execution by required parties, confirmation of no Default or Event of Default, and payment of fees and expenses to the Administrative Agent and affiliates. Loan Parties reaffirmed all covenants, representations, warranties, liens, and obligations under the amended documents.

• ·Original Credit Agreement dated December 1, 2021
• ·Prior amendments: First (March 17, 2023), Second (February 16, 2024), Third (June 4, 2024), Fourth (March 31, 2025), Fifth (July 18, 2025)
• ·Counsel mentioned: Cahill Gordon & Reindel LLP
• ·Governing law: State of New York

01-04-2026

Community Health Systems, Inc. completed the sale of substantially all assets and certain liabilities of Crestwood Medical Center and associated outpatient centers in Huntsville, Alabama, to The Health Care Authority of the City of Huntsville d/b/a Huntsville Hospital Health System on April 1, 2026, for $459 million in cash (subject to post-closing adjustments). The transaction resulted in an estimated pre-tax gain of $185 million ($138 million after tax), boosting pro forma cash by $450 million and improving stockholders' deficit. However, pro forma net operating revenues declined by $327 million, and net loss attributable to stockholders increased to $610 million from $509 million for the year ended December 31, 2025.

• ·Agreement entered into on January 20, 2026.
• ·Facility operations do not qualify as discontinued operations under ASC 205.
• ·Pro forma adjustments eliminate $327M revenues, $123M salaries/benefits, $63M supplies, $88M other operating expenses, $11M lease cost, $13M depreciation/amortization, and reflect $185M gain/(loss) on sale.

01-04-2026

Beyond Air, Inc. (NASDAQ: XAIR) announced the resignation of CEO Steve Lisi effective March 27, 2026, and the appointment of Robert Goodman, current Chief Commercial Officer and Director, as the new CEO effective March 26, 2026. The Board highlighted Goodman's commercial expertise to accelerate LungFit PH market adoption and growth, expecting a seamless transition with no operational disruptions. The change is positioned to drive broader customer deployment in U.S. and international inhaled nitric oxide markets.

• ·Steve Lisi led Beyond Air for nine years, overseeing development and launch of LungFit PH.
• ·Robert Goodman joined Beyond Air Board in June 2025 and served as Chief Commercial Officer from November 2025 to March 2026.
• ·LungFit PH has FDA approval and CE Mark for treatment of term and near-term neonates with hypoxic respiratory failure.

01-04-2026

HubSpot, Inc. (NYSE: HUBS) announced the appointment of Mike Berry, Chief Financial Officer of MongoDB, to its Board of Directors, effective April 1, 2026. Berry brings more than 30 years of experience in finance, operations, and general management from leading technology companies including NetApp and McAfee. CEO Yamini Rangan praised Berry's financial expertise, governance track record, and understanding of AI as invaluable for scaling HubSpot's agentic customer platform globally.

• ·Mike Berry holds a bachelor's degree in finance from Augsburg College and an MBA from the University of St. Thomas.
• ·Berry serves on the boards of directors of Rapid7 and Calix.
• ·Appointment announced via Exhibit 99.1 press release on April 1, 2026.

01-04-2026

Four Corners Property Trust (NYSE: FCPT) appointed Michael Friedland to its Board of Directors, effective April 1, 2026. Friedland brings over 30 years of experience in real estate finance, corporate credit underwriting, and banking, including over 20 years of executive leadership, most recently as Vice Chair of Global Corporate Banking at JPMorgan Chase Bank, N.A. until March 2026. CEO Bill Lenehan praised Friedland's expertise in supporting FCPT's balance sheet.

• ·Friedland started career at Bankers Trust Corporation on Real Estate Industries Team.
• ·Joined JPM in 1994 as Managing Director in Syndicated and Leveraged Finance Group.
• ·Head of Real Estate Special Credits and Workout Group from 2010 to 2012.
• ·Group Manager of Global Corporate Banking-Real Estate in 2012; promoted to Vice Chair in 2022.
• ·Holds M.B.A. in Finance from New York University and B.A. cum laude from Tufts University.

01-04-2026

Future Money Acquisition Corporation, a blank check SPAC, announced the pricing of its $100,000,000 initial public offering of 10,000,000 units at $10.00 per unit, with units to list on Nasdaq under FMACU beginning March 27, 2026, and closing expected March 30, 2026. Underwriters led by D. Boral Capital have a 45-day option to purchase up to 1,500,000 additional units for over-allotments. The sponsor is Future Wealth Capital Corp., with Mr. Siyu Li as ultimate beneficial owner.

• ·Each unit consists of one ordinary share and one right to 1/5 ordinary share upon initial business combination.
• ·Registration statement on Form S-1 (File No. 333-291996) effective March 26, 2026.
• ·Company incorporated as Cayman Islands exempted company.

01-04-2026

Akebia Therapeutics, Inc. (Nasdaq: AKBA) appointed biopharmaceutical leader Philip Vickers, Ph.D., President and CEO of Solu Therapeutics, to its Board of Directors effective April 1, 2026, citing his extensive experience in drug development and business strategy. Concurrently, Steven C. Gilman, Ph.D. retired from the Board effective the same date, after serving since the 2018 merger with Keryx. The changes occur as Akebia advances programs in kidney and rare diseases.

• ·Dr. Vickers has over three decades of biopharmaceutical experience, including CEO roles at Faze Medicines and Northern Biologics, and Executive VP and Global Head of R&D at Shire.
• ·Dr. Gilman previously served on Keryx Board since March 2016.
• ·Dr. Vickers holds a Ph.D. from the University of Toronto and has co-authored ~60 peer-reviewed publications and numerous patents.

01-04-2026

On March 31, 2026, the Compensation Committee of Tron Inc. approved an increase in the annual salary of President Taft Flittner, a named executive officer, from $100,000 to $120,000, effective immediately. The 8-K filing was signed by CEO Richard Miller on April 1, 2026. No other changes in officers or directors were reported.

• ·Tron Inc. is an emerging growth company.
• ·Common Stock trades under symbol TRON on The Nasdaq Capital Market.

01-04-2026

Cousins Properties Incorporated (Parent) and Cousins Properties LP (Borrower) entered into a Sixth Amended and Restated Credit Agreement dated April 1, 2026, amending the prior agreement from May 2, 2022, to establish a $1.2 billion revolving credit facility (Aggregate Revolving Credit Commitments). Bank of America, N.A. serves as Administrative Agent and L/C Issuer, with JPMorgan Chase Bank, N.A. as Syndication Agent, and other lenders including Truist Bank, PNC Bank, N.A., Morgan Stanley Bank, N.A., U.S. Bank National Association, Wells Fargo Bank, N.A., and TD Bank, N.A. as Documentation Agents. The agreement modifies interest rates, covenants, and other terms to provide ongoing liquidity.

• ·Published CUSIP Numbers: Deal 22279UAJ0, Revolver 22279UAK7
• ·Existing Credit Agreement dated May 2, 2022